Broccoli (Sprouts or Extract)
Can Halt the Growth of Breast Cancer Cells
There
are several very important substances in the sprouts of broccoli, one
of them being indole-3-carbinol. This component of broccoli and other
members of the Brassica genus, halts the growth of breast cancer cells
and likely prostate cancer. Other vegetables in the Brassica genus include
brussels sprouts, bok choy, kale, chard and turnips and they are also
likely to be helpful. It appears to be helpful for treating and
preventing breast and prostate cancer and indole-3-carbinol may also
help treat the disease.
Indole-3-carbinol works by halting the cell cycle in breast cancer cells
without actually killing the cells. The cell cycle is a rigidly prescribed
series of steps a cell must go through before it can divide in two, involving
the duplication of the cell's contents and a final split.
If you can alter specific components of the cell cycle, you can stop the
growth of cancer cells without killing normal cells. Indole-3-carbinol
interferes with the cell cycle in a way that hints at a totally new signaling
pathway in the cell. The chemical seems to be working by a very unusual
mechanism. It turns off a gene for an enzyme important in the cell's growth
cycle. The compound also works independently of the hormone estrogen, which
makes it a good candidate for use in combination therapy with drugs that
interfere with estrogen, such as tamoxifen.
What's exciting about this is that indole-3-carbinol has low toxicity but is
a very effective agent against breast cancer -- it's one of the most effective
agents at blocking tumorigenesis in rats. Given in the diet, indole-3-carbinol
can block 95 percent of all breast cancers in rats.
It appears that indole-3-carbinol does not act on estrogen at all, but rather
works through a different mechanism to halt the cell cycle. The chemicals
produced when indole-3-carbinol reacts with stomach acid are the ones
responsible for the anti-estrogen and certain toxic effects of the broccoli
compounds. Indole-3-carbinol specifically causes a sudden drop in the production
of the enzyme CDK6, or cyclin-dependent kinase 6. CDK6 is one of several protein
complexes targeted by hormones that regulate the progression of the cell cycle,
and was identified only three years ago.
Indole 3 carbinol as contained in sprouted vegetables seems a better idea
than drugs to treat breast cancer. As it is likely also to be very
beneficial in the treatment of prostate cancer, and the two diseases have very
similar contributing factors, it may be a good idea to get the entire family of beneficial
nutrients. The best way to do this would not be to eat broccoli but to consume
broccoli sprouts which are hundreds of times more potent than regular broccoli.
Researchers attempted to calculate
how much broccoli one would have to eat in order to produce a significant degree
of protection against cancer, based on epidemiologic evidence. They found that
one would have to eat about two pounds of an average broccoli a week in order to
reduce, say, one's risk of colon cancer by about 50%. It is impossible to
determine by the looks of this cruciferous vegetable alone or even with
knowledge of how and where it was grown whether you are buying the
'high-inducer' or 'low-inducer' broccoli. The enzyme-inducing abilities of
samples taken from 22 varieties of fresh and 7 brands of frozen mature broccoli
varied greatly. Only sophisticated scientific measurements can determine the
concentrations.
But fresh broccoli sprouts offer an
alternative. One can get away with eating 10 to 100 times lower quantities.
Three day old sprouts have the additional advantage that they're far more
uniform in their potency. Broccoli sprouts look and taste something like alfalfa
sprouts. The report also notes that small quantities of broccoli sprout extracts
markedly reduced the size of rat mammary tumors that were induced by chemical
carcinogens.
The researchers refer to the
concept of "chemoprotection" -- "deliberate efforts to increase the body's own
defense mechanisms to reduce susceptibility to carcinogens by administration of
substances that can be precisely identified, and ideally, delivered in the diet.
The interesting aspect of chemoprotection strategies is that they're almost
never organ-specific. Chemoprotection produces a general cancer protective
effect which blocks multiple steps -- a cascade of steps -- that are common to
cancer formation.
Nutrition and Cancer 2004;48(1):84-94
|